Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016
|
|
- Mariah Ray
- 5 years ago
- Views:
Transcription
1 1. M/s LG Life Sciences India Pvt. Ltd.,Basement Commercial SCO No. 321, Sector-29, Gurgaon, India 2. M/s Eli Lilly and Co (I) Pvt. Ltd., Bldg. No. 14, Gala No. 1 to 4, 1 st Fl, Arihant Comm. Complex, Opp. Koper Bus Stop, Purna-Bhi, Tal: Bhiwandi-14 (Thane-Zone5) Maharashtra , India 3. M/s Sanofi Synthelabo (India) Private Limited, Citylink Warehousing Complex, Village Vadpe, Tal: Bhiwandi , Thane Z5, India RECOMBINANT PRODUCT Recombinant Insulin Glargine 100IU/ml FFR Valid upto 18/03/2019 Insulin Lispro I.P. (r-dna origin) in Pre-Filled Pen 100IU/ml, 3ml Solution for Injection. Insulin Lispro Biphasic Injection I.P. [50% Insulin Lispro Protamine Suspension and 50% Insulin Lispro Injection (r-dna origin)], 100IU/ml in Pre-Filled Pen 3ml. Insulin Lispro Biphasic Injection I.P. [(75% Insulin Lispro Protamine Suspension and 25% Insulin Lispro Injection (r-dna origin)] 100IU/ml in Pre-Filled Pen 3ml. Insulin Human I.P. (r-dna origin); 100IU/ml, 3ml cartridge. Isophane Insulin Human Suspension I.P. (r-dna origin); 100IU/ml, 3ml cartridge. Biphasic Insulin Injection I.P. (r-dna origin)- 30% Solution Insulin & 70% Isophane Suspension Human, 100IU/ml, 3ml cartridge. Aflibercept solution for infusion (r-dna origin) Solution for infusion Each single use vial contains Aflibercept...100mg/200mg Strength...25mg/ml Page 1 of 5 FFR Valid upto 31/01/2018 FFR Valid upto 09/02/2019
2 4. M/s Lupin Limited, Shree Arihant Recombinant Insulin Glargine Injection 100 FFR Compound, Gala No.1 to 9, Bldg. No. Z1, 1 st IU/mL Valid upto 18/03/2019 Fl., Kalher Pipeline, Kalher, Bhiwandi, Tal: Bhiwandi (Thane-Zone5), Pin: , India 5. M/s UCB India Pvt. Ltd., 503/504, Peninsula Towers, G.K. Marg, Lower Parel, Mumbai , India. 6. M/s Ferring Pharmaceuticals Pvt. Ltd., Sunshine Tower, 24 th Floor, Senapati Bapat Marg, Dadar (West), Mumbai , India 7. M/s LG Life Sciences India Pvt. Ltd.,Basement Commercial SCO No. 321, Sector-29, Gurgaon, India Natalizumab 300mg concentrate for solution for infusion (r-dna origin) Interferon beta-1a 30µg (6 million IU)/0.5 ml (r- DNA origin) in Prefilled Pen and Prefilled Syringe Somatropin (Recombinant Human Growth Hormone) Bacteriostatic sodium chloride injection USP. Recombinant Human Growth Hormone (Somatropin)... 4 IU Recombinant Human Erythropoietin Injection IU/ 1.0 ml, IU/ 2.0 ml Sustained Release Recombinant Human Growth Hormone (Somatropin) contains.. 24 mg Recombinant Human Follicle Stimulating Page 2 of 5 FFR Valid upto 31/10/2018 *(Import License No. FFR is now transferred from M/s Biogen Idec Biotech India Pvt. Ltd. to M/s UCB India Pvt. Ltd.) FFR Valid upto 30/04/2019 SV Valid upto 31/03/2019
3 Hormone Injection Injection (Powder for solution) 8. M/s. Bioviz Technologies Pvt. Ltd. D.No /S/103/1, I & II Floors, Sagar Co-OP, Housing Society Road No. 2, Banjara Hills, MCH Circle -5 Mandal, Hyderabad Dist Each vial Contains: r- Human Follitropin IU/ 150 IU and Sterile Diluent (0.01% Polysorbate 20 in Saline) ml Recombinant Human Follicle Stimulating Hormone Solution for injection 75IU/0.15ml, 150IU/0.3ml, 225IU/0.45ml and 300IU/0.6ml in pre-filled Syringes. Recombinant Human Erythropoietin- (Bulk- Ready to fill) (2000IU/ml and 4000IU/ml) FFR Valid upto 18/01/ M/s. Novo Nordisk India Pvt. Ltd., Plot No. 32, 47-50, EPIP Area, Whitefield, Bangalore , India 10. M/s Bristol Myers Squibb India Pvt. Ltd., City Link Ware Houses Complex, Mumbai Nashik Highway, Taluka: Bhiwandi-16, District: Thane Z-5, Pin: , India. 11. M/s Merck Specialities Pvt. Ltd, Plot No. D- 116, MIDC., Bldg No. 2, 1 st Floor, Thane Belapure Road, Shir Vane, Navi Mumbai Insulin degludec/liraglutide (Xultophy ) (r-dna origin) Additional route of administration of Abatacept 125mg/ml solution for subcutaneous injection Follitropin alpha (Recombinant Follicle Stimulating Hormone) lyophilized powder in vials. Human Somatropin hormone Injection as Saizen Page 3 of 5 FF FF valid up to 30/09/2017 FFR Valid upto 21/04/2018
4 400706, Maharashtra, India 5.83mg/ml (1 cartridge of 1.03ml containing 6mg of somatropin) Human Somatropin hormone Injection as Saizen 8mg/ml (1 Cartridge of 1.5ml containing 12mg of Somatropin) Human Somatropin hormone Injection as Saizen 8mg/ml (1 Cartridge of 2.5ml containing 20mg of Somatropin) r-6hgh solution for injection. HUMAN VACCINE 1. M/s MSD Pharmaceuticals Pvt Ltd., City link, Ware Houses Complex, Mumbai- Nashik Highway, S.No , Village Vadapa, Tal-Bhiwandi, Dist-Thane, Maharashtra (Rotavirus Vaccine, Live, Oral, Pentavalent) oral solution Single dose of 2ml contains- Name of Active Ingredients G1 Reassortant G2 Reassortant G3 Reassortant G4 Reassortant P1 Reassortant Quantity IU/dose IU/dose IU/dose IU/dose IU/dose FFR valid up to 31/05/ M/s. Sanofi Pasteur India Private Limited, Inactivated Purified Vero cells Rabies vaccine (Powder in vial and diluent in Prefillled syringe) SV-1-32 Page 4 of 5
5 3. M/s. Sanofi Pasteur India Private Limited, Inactivated Purified Vero cells Rabies vaccine (Powder SV-5-42 in vial and Diluent in Prefillled syringe) 4. M/s. Sanofi Pasteur India Private Limited, 5. M/s. Sanofi Pasteur India Private Limited, Multidose presentation (10 doses, 10 vials) of Inactivated Influenza vaccine (Split Virion) Multidose presentation (10 doses, 10 vials) of Inactivated Influenza vaccine (Split Virion) SV-1-32 SV-5-42 VETERINARY VACCINE Nil Page 5 of 5
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015. Human vaccines
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015 S. No. Firm Name of Formulation Registration Certificate No. & Validity 1. M/s. Nirlac Chemicals,14 th
More informationStatus of Registration Certificate (Form 41) of Human Vaccines, Recombinant Products and Veterinary Vaccine issued from 01/01/2015 to 27/02/2015
Status of Registration Certificate (Form 41) of Human Vaccines, Recombinant Products and Veterinary Vaccine issued from 01/01/2015 to 27/02/2015 S. No. Firm Name of Formulation Registration Certificate
More informationStatus of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016 RECOMBINANT PRODUCTS S. No. Firm Name of Formulation Import License No. &
More informationStatus of Import License (Form 10) of Human Vaccines, Recombinant Products and Veterinary Vaccine issued from 01/01/2015 to 27/02/2015
Status of Import License (Form 10) of Human Vaccines, Recombinant Products and Veterinary Vaccine issued from 01/01/2015 to 27/02/2015 S. No. Firm Name of Formulation Import LicenseNo. & Validity HUMAN
More informationStatus of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/01/2017 to 31/12/2017
1. M/s Zuventus Healthcare Limited Office No. 5119,5 th Floor, Oberoi Garden Estate, Chandivali, Andheri (East) Mumbai, Tal: Sakinaka (Mumbai -Zone 4) Pin: 400072 2. M/s. Shantha Biotechnics Limited, Survey
More informationONLINE SUPPLEMENTARY APPENDIX. Webtable 1: Survey facilities random sampling
ONLINE SUPPLEMENTARY APPENDIX Webtable 1: Survey facilities random sampling Delhi, also known as the National Capital Territory (NCT) of Delhi, is divided into total 11 districts namely New Delhi, North
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 04.12.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. VIRCHOW BIOTECH PVT LTD - QUERY 2. M/S. MSN LABORATORIES PVT - CT-NOC & BE NOC LTD (3) 3. M/S. NATCO PHARMA LTD. - BE-NOC
More informationSUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT IP Solution for Oral Administration 2 ml single dose plastic dosing tube Brand Name: RotaTeq SUMMARY OF PRODUCT CHARACTERISTICS
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 25.04.2017 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ALEMBIC PHARMACEUTICALS 2. M/S. ALEMBIC PHARMACEUTICALS 3. M/S. ALEMBIC PHARMACEUTICALS 4. M/S. EMCURE PHARMACEUTICALS
More informationIraq NDI Iraq 04-J India 05-AH France Famar Lyon France 05-D UNITED ARAB EMIRATES. Iraqi Biocon Limited Indian 06-AA0-001
nam origmanufacturer nammanufacturer National code Mousel Scientific Iraq NDI Iraq 04-J00-042 Sandoz GmbH Austria for Sandoz GmbH by Sandoz Ilac Sanayi ve India 05-AH0-040 France Famar Lyon France 05-D00-024
More informationSUMMARY OF PRODUCT CHARACTRISTICS
1. NAME OF THE MEDICINAL PRODUCT Purified, Inactivated, Lyophilized Rabies Vaccine, Prepared on Vero Cells INDIRAB 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Qualitative Formula per dose of 0.5 ml (Single
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL
More informationTODAY LETTER DATED
TODAY LETTER DATED 26.06.2018 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. RESEARCH ASSOCIATES INDIA PVT.. 18670 PA APPROVAL LETTER LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY
More informationRasburicase 1.5 mg/ml powder and solvent for concentrate for solution for infusion. FASTURTEC
For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory This package insert is continually updated. Please read carefully before using a new pack. Rasburicase 1.5 mg/ml powder
More informationDirectorate General of Health Services Office of Drugs Controller General (India) (Biological Division)
Directorate General of Health Services Office of Drugs Controller General (India) (Biological Division) List of r-dna drug products approved in the country (Form 45 and 45A) from 1 st Jan 2015 to 30 th
More informationModern Drug House.
+91-8048941768 Modern Drug House https://www.moderndrughouse.in/ We are one of the leading suppliers and traders of a wide range of Vaccine and Pharmaceutical Products. Owing to its effectiveness, purity
More informationSummary of product characteristics As per Annexure C. SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1
Summary of product characteristics As per Annexure C SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1 1. NAME OF THE MEDICINAL PRODUCT. ANNEXURE C to MODULE I Inactivated Trivalent Influenza
More informationSUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IP Solution for injection 0.5-mL single dose vials and prefilled syringes BRAND NAME: PNEUMOVAX 23 SUMMARY OF PRODUCT CHARACTERISTICS
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 15.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1 M/S NATCO PHARMA LIMITED HYDERABAD MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. GENETIX BIOTECH ASIA PVT. LTD. 22073 APPROVAL
More informationInsulin Prior Authorization with optional Quantity Limit Program Summary
Insulin Prior Authorization with optional Quantity Limit Program Summary 1-13,16-19, 20 FDA LABELED INDICATIONS Rapid-Acting Insulins Humalog (insulin lispro) NovoLog (insulin aspart) Apidra (insulin glulisine)
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 14.12.2015 LVP DIVISION S. COMPANY NAME FTS /DIARY STATUS 01 M/S. AXA PARENTERALS LTD., ROORKEE 60262 APPROVAL 02 M/S. UNIJULES LIFE SCIENCES LTD., NAGPUR 61147 APPROVAL 03 M/S. INNVOL MEDICAL
More informationPRAC recommendations on signals
18 May 2017 EMA/PRAC/252869/2017 Pharmacovigilance Risk Assessment Committee (PRAC) Adopted at the 2-5 May 2017 PRAC meeting This document provides an overview of the recommendations adopted by the Pharmacovigilance
More informationFor the use only of Registered Medical Practitioners or a Hospital or a Laboratory HIBERIX
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory HIBERIX Haemophilus type b conjugated vaccine IP 1. NAME OF THE MEDICINAL PRODUCT Haemophilus type b conjugated vaccine
More informationGUIDELINE ON THE CATEGORISATION OF EXTENSION APPLICATIONS (EA) versus VARIATIONS APPLICATIONS (V) OCTOBER 2003
EUROPN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, implementation and legislation for consumer goods Pharmaceuticals : regulary framework and market authorisations Brussels, F2/AW D(2002)
More informationINSTITUTE OF NONDESTRUCTIVE TESTING & TRAINING
Schedule of for the month January 2016: 04-07 January 08-09 January 11 January Ultrasonic Testing (UT) 12-15 January 16-18 January 19 January Liquid Penetrant Testing(PT) 20-22 January 23 January 25 January
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT SHINGLES (HERPES ZOSTER) VACCINE (LIVE) BP (Oka/Merck) Powder and solvent for suspension for injection 0.65 ml Single Dose Vial of powder
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 21.06.2016 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. GLOBAL PHARMA HEALTHCARE PVT. LTD., THIRUPORUR 27509 APPROVAL BIOLOGICAL DIVISION NAME OF COMPANY DY.NO. STATUS
More informationThis program applies to Commercial, GenPlus and Health Insurance Marketplace formularies.
OBJECTIVE The intent of the GLP-1 (glucagon-like peptide-1) Agonists [Adlyxin (lixisenatide), Byetta (exenatide), Bydureon (exenatide extended-release), Tanzeum (albiglutide), Trulicity (dulaglutide),
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 05.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE OF DOCUMENT 1. M/S. ARRIGO INTERNATIONAL,INDORE 2 M/S. EUROLIFE HEALTHCARE PVT. LTD. HARIDWAR NEW DRUG S. NAME OF APPLICANT DIARY TYPE
More informationThis vaccine is indicated for the prevention of poliomyelitis in infants, children and adults, for primary and booster vaccinations.
NAME OF THE MEDICINAL PRODUCT IMOVAX POLIO, suspension for injection in a prefilled syringe or multidose Poliomyelitis vaccine (inactivated) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose (0.5 ml)
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 11.04.2017 BIOLOGICAL DIVISION NAME OF COMPANY DY. NO. STATUS M/S ZUVENTUS HEALTHCARE LTD 6981 APPROVAL M/S TECHINVENTION LIFE SCIENCES 1208 CLARIFICATION M/S CADILA PHARMACEUTICALS LTD
More informationBRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
More informationCaretropin. Daewoong Recombinant Human Growth Hormone. Recombinant Escherichia coli. Growth hormone deficiency
Caretropin Daewoong Recombinant Human Growth Hormone Active ingredient Host cell Indication Formulation Administration Somatropin Recombinant Escherichia coli Growth hormone deficiency 1. Lyophilized powder
More informationType I Type II Insulin Resistance
Insulin An aqueous hormonal solution made in the pancreas. Affects metabolism by allowing glucose to leave the blood and enter the body cells, preventing hyperglycemia. It is measured in units, e.g. 100
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sat, 15 Sep 2018 23:09:24 GMT) CTRI Number CTRI/2009/091/000804 [Registered on: 04/06/2010] - Last Modified On 02/09/2014 Post Graduate Thesis Type of Trial
More informationShort-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins
Recommended Insulin Products This guideline states the Gloucestershire Joint Formulary recommended, first choice insulin products. The intention is to support the choice of treatment for new patients,
More informationList of changes in Out-Patients Formulary
List of changes in Out-Patients Formulary Change in prescriber criteria Alpha Tocopheryl (Vitamin E) suspension 100mg/mL, tablets 50-150mg, tablets 670mg Atorvastatin tablets Bezafibrate tablets 400mg
More informationConverting lantus to humalog 75 25
P ford residence southampton, ny Converting lantus to humalog 75 25 This page includes the following topics and synonyms: Insulin Dosing in Type 2 Diabetes, Insulin Dosing in Type II Diabetes. Thiazide
More informationSUMMARY OF PRODUCT CHARACTRISTICS
1. NAME OF THE MEDICINAL PRODUCT Typhoid (Vi Capsular Polysaccharide)-Tetanus Toxoid Conjugate Vaccine. Typbar-TCV 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Qualitative Formula per dose of 0.5 ml (Single
More informationBharat Biotech. Hyderabad. Type of PAC (Supplement and Notifiable / Permission Granted by CDSCO) S. No Product
Bharat Biotech Hyderabad S. No Product Type of PAC (Supplement and / Permission Granted by CDSCO) PAC Details Date of NOC in manufacturing process of Oral Polio F.No. 12-63/BHARAT/(PACOPV)/13-BD 30.08.2013
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 10 Mar 2019 08:06:46 GMT) CTRI Number Last Modified On 29/11/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationTABLE 7 ADVANTAGES AND DISADVANTAGES OF TOXOID VACCINES SUBUNIT VACCINES Applications of Subunit Vaccines TABLE 8 APPLICATIONS OF
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
More informationInsulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children
Insulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children December 2008 This technology summary is based on information available at the time of research and a limited literature
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 17.07.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY TYPE OF NO. 1. M/S. CIREX PHARMACEUTICALS LTD - QUERY 2. M/S. LUPIN LIMITED - ADDITIONAL SITES REGISTRATION S.NO. NAME OF APPLICANT DIARY
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 29.11.2016 COSMETICS DIVISION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. WELLA INDIA PVT. LTD., MUMBAI 29233, 29524 & 28513 APPROVAL 2. M/S. PROCTER & GAMBLE HOME PRODUCTS PVT. LTD.,
More informationPhase 3 efficacy study of a new pentavalent bovine-human reassortant rotavirus vaccine in India
Phase 3 efficacy study of a new pentavalent bovine-human reassortant rotavirus vaccine in India 12 th International Rotavirus Symposium 7-9 September 2016, Melbourne Dr Prasad Kulkarni, MD Serum Institute
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 27.08.2015 NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. INTAS PHARMACEUTICALS LIMITED - CT NOC (2) 2. M/S. PFIZER LIMITED - QUERY 3. M/S. MSN LABORATORIES - ADDITIONAL SITE 4. M/S.
More informationList of Recombinant DNA based Drugs Approved in the Country (Form-45) 1st Jan st Dec 2013
S.No. 1 Name of the firm Ferring Date of Approval 4-Apr-10 License No. Import-450/10 2 G.C.Chemie 23-Jun-10 IMP-572/10 3 R.K. Medicare 9-Sep-10 IMP-783/10 4 5 List of Recombinant DNA based Drugs Approved
More informationCentral Inspection Plan Using Risk Based Approach Of Vaccine Manufacturing Units for 2017
, follow-up, failure A NORTH ZONE 1 M/s Biomed Pvt. Ltd, C-96, Site I, Bulandshahar Road, Ind. Area, Ghaziabad. 1. Oral Polio Vaccine IP, 2. Vi Typhoid Vaccine (Bio Typh TM ) IP, 3. Haemophilus Type-B
More informationHeat Stable Oral Rotavirus Vaccine
Heat Stable Oral Rotavirus Vaccine Davinder Gill, PhD 11 th International Rotavirus Symposium 4 th September 2014, New Delhi 1 We are working with a pre-approved oral rotavirus vaccine Licensed in the
More informationDrug Effectiveness Review Project Summary Report Long acting Insulins
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationVACCINE MANAGEMENT. Recommendations for Handling and Storage of Selected Biologicals. January 2001 DEPARTMENT OF HEALTH AND HUMAN SERVICES
VACCINE MANAGEMENT Recommendations for Handling and Storage of Selected Biologicals January 2001 DEPARTMENT OF HEALTH AND HUMAN SERVICES DTaP: Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis Vaccine
More informationSummary of product characteristics As per Annexure C. SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1
Summary of product characteristics As per Annexure C SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1 1. NAME OF THE MEDICINAL PRODUCT. ANNEXURE C to MODULE I Measles, Mumps & Rubella Vaccine
More informationVaccine Technologies and Global Markets
A BCC Research Pharmaceutical Report and Global Markets PHM014D Use this report to: Learn about the strengths and weaknesses of each category of human and veterinary vaccine to prevent or treat infectious
More informationFARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)
Type 2 Medications Drug Class How It Works Brand and Generic Names Manufacturers Usual Starting Dose The kidneys filter sugar and either absorb it back into your body for energy or remove it through your
More informationNIT 97 - APPROVED DRUG LIST
1 EDL0422 Name of the and Strength Chlorine based compound NADCC Tablets 75 mg With Available Chloroine 45 mg BIS* 1 pack of 1000 tablets VAT 440748 71.0000 74.5500 ADHISH INDUSTRIES 2 120092 Cloxacillin
More informationArtesunate 120mg powder for injection (Guilin Pharmaceutical Co., Ltd), MA90 LABELLING. Page 1 of 6
LABELLING Page 1 of 6 PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer Carton 1. NAME OF THE MEDICINAL PRODUCT Artesun 120mg * 2. STATEMENT OF ACTIVE SUBSTANCE Each vial contains 120 mg artesunate powder
More informationNEW MEDICINE APPLICATIONS BROUGHT TO THE BORDERS FORMULARY COMMITTEE (BFC) AND AREA DRUG & THERAPEUTICS COMMITTEE (ADTC) 2015/16
New Medicine Product/Device Endorsement Categories NEW MEDICINE APPLICATIONS BROUGHT TO THE BORDERS FORMULARY COMMITTEE (BFC) AND AREA DRUG & THERAPEUTICS COMMITTEE (ADTC) 2015/16 A B C D E F recommended
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 01.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S TYCHE INDUSTRIES LTD., ANDHRA PRADESH, INDIA IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. PIRAMAL ENTERPRISES LTD. 25471 APPROVAL
More informationHow to Fight Diabetes and Win. Diabetes. Medications
How to Fight Diabetes and Win Diabetes Medications MEDICATIONS FOR DIABETES According to the American Diabetes Association, 85% of adults diagnosed with diabetes take insulin and/or oral medication to
More informationSTEP THERAPY CRITERIA
CATEGORY DRUG CLASS BRAND NAME (generic) STEP THERAPY CRITERIA AMYLIN ANALOG: SYMLIN/SYMLINPEN (pramlintide acetate) ANTIDIABETIC AGENTS GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1): ADLYXIN (lixisenatide)
More informationSubsequent New Drugs Division. M/s.Troikaa. M/s. Olive Healthcare. Biological Division. M/s. Wockhardt Ltd. Global Clinical Trial Division
: The34 th SEC (Endocrinology & Metabolism) meeting held on 25.04.2017 at CDSCO HQ New Delhi and recommended the following: Age Subsequent New Drugs Division 1 12-146/2016-DC (Pt- Zim-Snd) Vitamin D3 (Cholecalciferol)
More informationMERIEUX INACTIVATED RABIES VACCINE (MIRV)
MERIEUX INACTIVATED RABIES VACCINE (MIRV) Rabies Vaccine What is in this leaflet Consumer Medicine Information This leaflet answers some common questions about Merieux Inactivated Rabies Vaccine (MIRV).
More informationHOW TO USE... 5mg. Pocket Guide
HOW TO USE... Pocket Guide 4 ZOMACTON [somatropin (rdna origin)] for Injection Supplies ZOMACTON 5 mg (powder) Preparation syringe Syringe and injection needle Diluent (liquid) Diluent (liquid) contains
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS Revised: October 2010 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Caninsulin 40 iu/ml Suspension for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:
More informationExperience with the first wp based fully liquid hexavalent vaccine.
Experience with the first wp based fully liquid hexavalent vaccine. EasySix TM Vaccine R K Suri Senior Advisor & Former Chief Executive- Biologicals Panacea Biotec Ltd New Delhi, INDIA October 31, 2018
More informationList Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities)
Edition: Version 11-19th of July 2018 List of A & B Products List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities) As from the version
More informationArtesunate 60 mg for injection WHOPAR part 5 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 LABELLING
LABELLING 1 PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton (pack of 1 vial and 2 ampoules) 1. NAME OF THE MEDICINAL PRODUCT Artesun * 2. STATEMENT OF ACTIVE SUBSTANCE Each vial contains 60 mg artesunate
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 03.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S LUPIN TARAPUR, MAHARASHTRA & WC 2. M/S JPN PHARMA PVT. PALGHAR, MAHARASHTRA WC 3. M/S OPTIMUS DRUGS A.P. WC VACCINE DIVISION S.
More informationADMELOG, NOVOLIN, NOVOLOG, and FIASP
ADMELOG, NOVOLIN, NOVOLOG, and FIASP Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationRECONSTITUTION, DOSING AND ADMINISTRATION
Prescribing Information can be found within this document CORRECT RECONSTITUTION FOR SC AND IV ADMINISTRATION VELCADE (bortezomib) 3.5 mg powder for solution for injection is available for intravenous
More informationNew Drugs Division. Frequently Asked Questions (FAQs) on Approval of new Phytopharmaceutical Drugs
Central Drugs Standard Control Organization Directorate General of Health Services Ministry of Health and Family Welfare Government of India New Drugs Division Frequently Asked Questions (FAQs) on Approval
More informationGemigliptin Tartrate Sesquihydrate Tablets 50mg
For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory This package insert is continually updated: Please read carefully before using a new pack. Gemigliptin Tartrate Sesquihydrate
More informationPARENTERAL PREPARATIONS
PARENTERAL PREPARATIONS INTRODUCTION Parenteral (Gk, para enteron, beside the intestine) dosage forms differ from all other drug dosage forms, because they are injected directly into body tissue through
More informationSTATE DISTRICT BRANCH ADDRESS CENTRE IFSC CONTACT1 CONTACT2 CONTACT3 MICR_CODE MR. HITESH P. MEHTA - MOBILE LANDLINE
STATE DISTRICT BRANCH ADDRESS CENTRE IFSC CONTACT1 CONTACT2 CONTACT3 MICR_CODE GUJARAT SURAT GHOD DHOD UNION SQUAR, UNION PARK, GHOD DOD ROAD, SURAT - 395 007 SURAT NICB0000103 GUJARAT SURAT SURAT ANNAPURNA
More informationH1N1 Vaccine Based on CDCs ACIP Meeting, July 29, 2009
August 6, 2009 H1N1 Vaccine Based on CDCs ACIP Meeting, July 29, 2009 CDC s Advisory Committee on Immunization Practices (ACIP), a panel made up of medical and public health experts, met July 29, 2009,
More informationLegal Supplement Part B Vol. 57, No. 6 18th January, NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS
Legal Supplement Part B Vol. 57, No. 6 18th January, 2018 11 LEGAL NOTICE NO. 5 REPUBLIC OF TRINIDAD AND TOBAGO FOOD AND DRUGS ACT, CHAP. 30:01 NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS ISSUED
More informationGLOBAL MARKETS FOR DIABETES THERAPEUTICS AND DIAGNOSTICS
GLOBAL MARKETS FOR DIABETES THERAPEUTICS AND DIAGNOSTICS HLC029D January 2013 Paul Evers Project Analyst ISBN: 0-89336-238-7 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
More informationDiabetes Update: Keeping patients safe. Victoria Ruszala MFRPSII North Bristol NHS Trust
Diabetes Update: Keeping patients safe Victoria Ruszala MFRPSII North Bristol NHS Trust Declaration of Interests I have received funding from the following companies for providing education sessions, attending
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Wed, 22 Aug 2018 08:47:30 GMT) CTRI Number CTRI/2009/091/000605 [Registered on: 18/01/2011] - Last Modified On 15/02/2013 Post Graduate Thesis Type of Trial
More informationList of Designated High-Cost Drugs
List of Designated High-Cost Drugs UPDATED APRIL 25, 2018 For details on the High-Cost Drug policy, see Section 5.8 of the PharmaCare Policy Manual. Recent updates appear in red. Deletions are listed at
More informationFile no./drug Name Name of firm/ Institute Recommendations. New Drugs Division
Recommendations: I approve the minutes of 52 nd SEC (Oncology & hematology) held on 13.04.2017 at CDSCO HQ New Delhi and recommended the following: Agenda 1 12-63/16-DC Ferric Pyrophosphate citrate solution
More informationUpdates on Rotasiil development
Updates on Rotasiil development 13 th International Rotavirus Symposium Minsk, Belarus 30 August 2018 Dr Sajjad Desai MD Serum Institute of India Pvt Limited, Pune Rotasiil Bovine-human reassortant strains
More informationUpdated: 26 August 2010
Australian Technical Advisory Group on Immunisation (ATAGI) Updated advice on the use of pandemic and seasonal influenza vaccines in children
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 20 Jan 2019 21:39:27 GMT) CTRI Number CTRI/2009/091/000777 [Registered on: 11/01/2010] - Last Modified On Post Graduate Thesis Type of Trial Type of
More informationPackage leaflet: Information for the user. GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon
Package leaflet: Information for the user GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon Read all of this leaflet carefully before you are given this injection because it
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Tue, 16 Apr 2019 03:04:45 GMT) CTRI Number Last Modified On 29/11/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationWHO International Biological Reference Preparations Held and distributed by the WHO International Laboratories for Biological Standards
WHO International Biological Preparations Activin A, human, recombinant. Lyophilized. 5 units / Reagent, 1998 No. 897 49th NIBSC 91/626 98.1882 Arginine vasopressin. Lyophilized. 8.2 IU / Standard, 1978
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 21 Apr 2019 03:53:36 GMT) CTRI Number Last Modified On 11/03/2019 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationINSULIN OVERVIEW. Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro min. 3-5 hrs min.
INSULIN OVERVIEW Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro Humalog 15-30 min 30-90 min 3-5 hrs aspart glulisine Short-Acting Regular insulin NovoLog Apidra
More informationSOMATULINE LA 30mg Lanreotide
SOMATULINE LA 30mg Lanreotide Consumer Medicine Information What is in this leaflet? Please read this leaflet carefully. It provides some information about your medicine. If you have any questions or are
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 07 Oct 2018 14:20:17 GMT) CTRI Number Last Modified On 13/02/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationSAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB
Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0166BDB Publication Date: January 2013 GlobalData. This report is a licensed product
More informationBotulinum Toxin Type A for Injection Ph.Eur. Brand Name: BOTO GENIE
Summary of Product Characteristics of Botulinum Toxin Type A for Injection Ph.Eur. Brand Name: BOTO GENIE Manufactured By: BIO-MED (P) LTD. C-96, Site No. 1, Bulandshahr Road Industrial Area, Ghaziabad
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Fri, 28 Sep 2018 17:28:30 GMT) CTRI Number Last Modified On 25/10/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationPackage leaflet: Information for the user. Poliomyelitis Vaccine (Inactivated) suspension for injection in pre-filled syringe
Package leaflet: Information for the user Poliomyelitis Vaccine (Inactivated) suspension for injection in pre-filled syringe Read all of this leaflet carefully before you or your child is vaccinated because
More informationongoing Insulin degludec/liraglutid 1 daily ongoing x daily
Resolution by the Federal Joint Committee on an amendment to the Pharmaceutical Directive (AM-RL): Appendix XII Resolutions on the benefit assessment of pharmaceuticals with new active ingredients, in
More informationArticle Gonadotrophin products: empowering patients to choose the product that meets their needs
RBMOnline - Vol 15 No 1. 2007 31-37 Reproductive BioMedicine Online; www.rbmonline.com/article/2814 on web 1 May 2007 Article Gonadotrophin products: empowering patients to choose the product that meets
More informationDiluent Benzyl alcohol 45 mg Meta-cresol 3.3 mg Sodium chloride 45 mg Water for injections to 1 ml Water for injections to 5 ml
PRODUCT INFORMATION ZOMACTON 4 mg and 10 mg Somatropin (rbe) 1 NAME OF THE DRUG ZOMACTON contains somatropin which is a protein having the structure (191 amino acid residues) of the major component of
More information